Cui Lu-Ying, Ding Ming-Xing
College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.
Zhen Ci Yan Jiu. 2016 Dec 25;41(6):550-5.
Electroacupuncture (EA) has been demonstrated effective for pain relief. However, repeated application may decline analgesic effect of EA, which is termed EA tolerance, that reduces the clinical efficacy of EA. Therefore, it has attracted attention from researchers in recent years and the progresses include:(1) acute and chronic EA tolerance animal models have been established; (2) cross-tolerance between EA and morphine; (3) Anti-opioid substances, including cholecystokinin, orphanin FQ and angiotensin Ⅱ, have been reported to contribute to EA tolerance; (4) glutamate receptors and transporters, 5-hydroxytryptamine and norepinephrine have been revealed involvement in EA tolerance; (5) cyclic adenosine monophosphate, cyclic guanosine monophosphate and Ca have been reported to be the second messengers cellularly in EA tolerance. The current EA tolerance effect lacks in-depth researches. Therefore, studies on its molecular mechanisms and signaling pathway are necessarily required.
电针(EA)已被证明对缓解疼痛有效。然而,重复应用可能会降低电针的镇痛效果,这被称为电针耐受,它会降低电针的临床疗效。因此,近年来它引起了研究人员的关注,进展包括:(1)已建立急性和慢性电针耐受动物模型;(2)电针与吗啡之间的交叉耐受;(3)据报道,包括胆囊收缩素、孤啡肽和血管紧张素Ⅱ在内的抗阿片物质会导致电针耐受;(4)已揭示谷氨酸受体和转运体、5-羟色胺和去甲肾上腺素参与电针耐受;(5)据报道,环磷酸腺苷、环磷酸鸟苷和钙在细胞内是电针耐受的第二信使。目前对电针耐受效应缺乏深入研究。因此,有必要对其分子机制和信号通路进行研究。